The landscape of 8q24 cytoband in gastric cancer (Review)

• Published in: Oncology letters Vol. 27; no. 1; p. 1
• Main Authors: Larios-Serrato, Violeta, Valdez-Salazar, Hilda-Alicia, Ruiz-Tachiquin, Martha-Eugenia
• Format: Journal Article
• Language: English
• Published: Athens Spandidos Publications 01-04-2024; Spandidos Publications UK Ltd
• Subjects: Cancer; Chromosomes; DNA sequencing; Family medical history; Gastric cancer; Genes; Genomes; Genomics; Mortality; Nucleotide sequencing; Single nucleotide polymorphisms; Stomach cancer
• ISSN: 1792-1074; 1792-1082
• DOI: 10.3892/ol.2024.14311

Worldwide, gastric cancer (GC) is estimated to be the fifth most common type of cancer type in both sexes, ranking sixth for new cases, with >640,850 cases per year, and fourth in terms of mortality rate. Cancer presents numerical and structural alterations in chromosomes, often through gains and losses of regions. In GC, there are multiple genetic alterations, in which those located in cytoband 8q24 have been frequently described; essential genes are present in this cytoband, regulating the homeostasis of crucial biological processes, such as the MYC gene, which induces expression of selective genes to promote cell growth and proliferation. Conversely, DNA sequence variations can also occur when a single nucleotide in the genome sequence is altered, and this is termed a single nucleotide polymorphism (SNP). These alterations, which can serve as a biological marker, are present in at least 1% of the population and assist in identifying genes associated with GC. In the present review, 12 genes present in cytoband 8q24 related to GC (NSMCE2, PCAT1, CASC19, CASC8, CCAT2, PRNCR1, POU5F1B, PSCA, JRK, MYC, PVT1 and PTK2) are discussed. The PSCA gene was cited more frequently than others; it has four known SNPs associated with GC (rs2978980, rs2294008, rs2976392 and rs9297976). Thus, these SNPs should be further studied in different populations to determine their risk value in patients with GC. Key words: 8q24, cytoband, gastric cancer, genes, single nucleotide polymorphism